Rectify Pharmaceuticals
- Founded: 2020
- Location: Cambridge, MA
- Employee range: 0 - 0
- Clinical stage: RD
- Therapy area: ABC transporter mediated diseases
- Drug types: RAR, HEP, OPH, NEU
- Lead product: Undisclosed
- Product link: https://rectifypharma.com/
- Funding: $100M A Oct 2021
rectifypharma.com linkedin.com job board
Short description:
Positive Functional Modulators disease-modifying precision therapeutics that restore ABC transporter function
Drug notes:
Contact us to add description: recruit@workinbiotech.com
Long description:
Rectify Pharmaceuticals is developing therapeutics that restore the function of ABC transporters. ABC transporters include a family of proteins that actively export a diverse range of substrates across lipid membranes, with their disruption linked to various serious diseases. Through the use of their breakthrough ABC-transporter product platform, Rectify is efficiently and rapidly discovering first-in-class small molecule therapies that can restore ABC transporter function for rare and common diseases.
Jobs:
© 2024 Work In Biotech LLC
Personal dataTerms of ServicePrivacy PolicyContact: recruit@workinbiotech.com
Personal dataTerms of ServicePrivacy PolicyContact: recruit@workinbiotech.com